Systemic Spread Is an Early Step in Breast Cancer

Cancer Cell

Volumn 13, Issue 1, 2008, Pages 58-68

  Hüsemann, Yves ^a   Geigl, Jochen B ^a   Schubert, Falk ^b,g   Musiani, Piero ^c   Meyer, Manfred ^a   Burghart, Elke ^a   Forni, Guido ^d   Eils, Roland ^b,e   Fehm, Tanja ^f   Riethmüller, Gert ^h   Klein, Christoph A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^h UNIVERSITY OF MUNICH   (Germany)

Author keywords

CELLCYCLE

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER STAGING; CARCINOMA IN SITU; CARCINOMATOSIS; CELL INVASION; CONTROLLED STUDY; DUCTAL CARCINOMA IN SITU; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KARYOTYPE; LUNG; MAJOR CLINICAL STUDY; METASTASIS; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; WILD TYPE;

MUS; MUS MUSCULUS;

EID: 37349079197     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.12.003     Document Type: Article

References (41)

1. Al-Kuraya K., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 64 (2004) 8534-8540
2. Astolfi A., Landuzzi L., Nicoletti G., De Giovanni C., Croci S., Palladini A., Ferrini S., Iezzi M., Musiani P., Cavallo F., et al. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. Am. J. Pathol. 166 (2005) 1205-1216
3. Boggio K., Nicoletti G., Di Carlo E., Cavallo F., Landuzzi L., Melani C., Giovarelli M., Rossi I., Nanni P., De Giovanni C., et al. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J. Exp. Med. 188 (1998) 589-596
4. Braun S., Pantel K., Muller P., Janni W., Hepp F., Kentenich C.R., Gastroph S., Wischnik A., Dimpfl T., Kindermann G., et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med. 342 (2000) 525-533
5. Braun S., Vogl F.D., Naume B., Janni W., Osborne M.P., Coombes R.C., Schlimok G., Diel I.J., Gerber B., Gebauer G., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 353 (2005) 793-802
6. Chin K., de Solorzano C.O., Knowles D., Jones A., Chou W., Rodriguez E.G., Kuo W.L., Ljung B.M., Chew K., Myambo K., et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36 (2004) 984-988
7. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295 (2002) 2387-2392
8. Curcio C., Di Carlo E., Clynes R., Smyth M.J., Boggio K., Quaglino E., Spadaro M., Colombo M.P., Amici A., Lollini P.L., et al. Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. J. Clin. Invest. 111 (2003) 1161-1170
9. Cutuli B., Cohen-Solal-Le Nir C., De Lafontan B., Mignotte H., Fichet V., Fay R., Servent V., Giard S., Charra-Brunaud C., Auvray H., et al. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur. J. Cancer 37 (2001) 2365-2372
10. Daniel C.W., De Ome K.B., Young J.T., Blair P.B., and Faulkin Jr. L.J. The in vivo life span of normal and preneoplastic mouse mammary glands: A serial transplantation study. Proc. Natl. Acad. Sci. USA 61 (1968) 53-60
11. Deome K.B., Faulkin Jr. L.J., Bern H.A., and Blair P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 19 (1959) 515-520
12. Di Carlo E., Diodoro M.G., Boggio K., Modesti A., Modesti M., Nanni P., Forni G., and Musiani P. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab. Invest. 79 (1999) 1261-1269
13. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-173
14. Engel J., Eckel R., Kerr J., Schmidt M., Furstenberger G., Richter R., Sauer H., Senn H.J., and Holzel D. The process of metastasisation for breast cancer. Eur. J. Cancer 39 (2003) 1794-1806
15. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
16. Fehm T., Braun S., Muller V., Janni W., Gebauer G., Marth C., Schindlbeck C., Wallwiener D., Borgen E., Naume B., et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 107 (2006) 885-892
17. Fidler I.J., and Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197 (1977) 893-895
18. Heim S., and Mitelman F. Cancer Cytogenetics. Second Edition (1995), Wiley-Liss, New York
19. Howe L.R., Watanabe O., Leonard J., and Brown A.M. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res. 63 (2003) 1906-1913
20. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., and Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3 (2003) 537-549
21. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
22. Klein C.A. The systemic progression of human cancer: A focus on the individual disseminated cancer cell - the unit of selection. Adv. Cancer Res. 89 (2003) 35-67
23. Klein C.A., Schmidt-Kittler O., Schardt J.A., Pantel K., Speicher M.R., and Riethmuller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl. Acad. Sci. USA 96 (1999) 4494-4499
24. Klein C.A., Seidl S., Petat-Dutter K., Offner S., Geigl J.B., Schmidt-Kittler O., Wendler N., Passlick B., Huber R.M., Schlimok G., et al. Combined transcriptome and genome analysis of single micrometastatic cells. Nat. Biotechnol. 20 (2002) 387-392
25. Klein C.A., Wilke M., Pool J., Vermeulen C., Blokland E., Burghart E., Krostina S., Wendler N., Passlick B., Riethmueller G., and Goulmy E. The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J. Exp. Med. 196 (2002) 359-368
26. Kronqvist P., Kuopio T., Nykanen M., Helenius H., Anttinen J., and Klemi P. Predicting aggressive outcome in T1N0M0 breast cancer. Br. J. Cancer 91 (2004) 277-281
27. Maglione J.E., Moghanaki D., Young L.J., Manner C.K., Ellies L.G., Joseph S.O., Nicholson B., Cardiff R.D., and MacLeod C.L. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res. 61 (2001) 8298-8305
28. McShane L.M., Radmacher M.D., Freidlin B., Yu R., Li M.C., and Simon R. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 18 (2002) 1462-1469
29. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., and Massague J. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
30. Muller W.J., Sinn E., Pattengale P.K., Wallace R., and Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54 (1988) 105-115
31. Riethmuller G., and Klein C.A. Early cancer cell dissemination and late metastatic relapse: Clinical reflections and biological approaches to the dormancy problem in patients. Semin. Cancer Biol. 11 (2001) 307-311
32. Schardt J.A., Meyer M., Hartmann C.H., Schubert F., Schmidt-Kittler O., Fuhrmann C., Polzer B., Petronio M., Eils R., and Klein C.A. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8 (2005) 227-239
33. Schlimok G., Funke I., Holzmann B., Gottlinger G., Schmidt G., Hauser H., Swierkot S., Warnecke H.H., Schneider B., Koprowski H., et al. Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc. Natl. Acad. Sci. USA 84 (1987) 8672-8676
34. Schmidt-Kittler O., Ragg T., Daskalakis A., Granzow M., Ahr A., Blankenstein T.J., Kaufmann M., Diebold J., Arnholdt H., Muller P., et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc. Natl. Acad. Sci. USA 100 (2003) 7737-7742
35. Stasinopoulos I.A., Mironchik Y., Raman A., Wildes F., Winnard Jr. P., and Raman V. HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. J. Biol. Chem. 280 (2005) 2294-2299
36. Turk V., Turk B., Guncar G., Turk D., and Kos J. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzyme Regul. 42 (2002) 285-303
37. Tusher V., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98 (2001) 5116-5121
38. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
39. van de Wouw A.J., Janssen-Heijnen M.L., Coebergh J.W., and Hillen H.F. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur. J. Cancer 38 (2002) 409-413
40. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., and Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 (2004) 927-939
41. Zohlnhofer D., Richter T., Neumann F., Nuhrenberg T., Wessely R., Brandl R., Murr A., Klein C.A., and Baeuerle P.A. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol. Cell 7 (2001) 1059-1069